Participants diagnosed with steatosis were observed to be older and exhibited a higher incidence of metabolic abnormalities, including elevated HOMA, glucose, LDL cholesterol, triglycerides, and insulin, coupled with decreased HDL cholesterol. This evidence concerns the gene INS and steatosis.